FigureĀ 1.
Treatment algorithm for MDS.1IPSS-R lower-risk: very low and low; higher-risk: intermediate, high, and very high. 2IPSS-M lower-risk: very low, low, and moderate low; higher-risk: moderate high, high, and very high. 3Data from HLA-matched related and unrelated donor, and if not available, from alternative donors such as haploidentical, mismatched unrelated or cord blood after RIC or myeloablative conditioning regimens. BM, bone marrow; IST, immunosuppressive treatment, S-EPO, serum erythropoietin.

Treatment algorithm for MDS.1IPSS-R lower-risk: very low and low; higher-risk: intermediate, high, and very high. 2IPSS-M lower-risk: very low, low, and moderate low; higher-risk: moderate high, high, and very high. 3Data from HLA-matched related and unrelated donor, and if not available, from alternative donors such as haploidentical, mismatched unrelated or cord blood after RIC or myeloablative conditioning regimens. BM, bone marrow; IST, immunosuppressive treatment, S-EPO, serum erythropoietin.

Close Modal

or Create an Account

Close Modal
Close Modal